# Lecture 9: Coronary Circulation ## Unit 1.7: Cardiovascular System --- ## Learning Objectives By the end of this lecture, students will be able to: 1. Describe the anatomy of coronary arteries and veins 2. Explain the unique features of coronary blood flow 3. Describe the regulation of coronary blood flow 4. Explain coronary autoregulation and reserve 5. Describe the pathophysiology of myocardial ischemia 6. Apply coronary physiology to clinical scenarios --- ## Coronary Anatomy Review The heart's blood supply originates from two main coronary arteries that arise from the aortic root immediately above the aortic valve. The right coronary artery provides blood to the right side of the heart and, in most individuals, the inferior portion of the left ventricle. The right coronary artery gives off the SA nodal artery in approximately 60% of people, supplying the sinoatrial node. It provides acute marginal branches to the right ventricle and, in the 70% of the population with right-dominant circulation, gives rise to the posterior descending artery that supplies the posterior interventricular septum and inferior left ventricle. The AV nodal artery arises from the right coronary artery in approximately 90% of individuals. The left main coronary artery bifurcates shortly after its origin into the left anterior descending artery and the left circumflex artery. The left anterior descending artery courses in the anterior interventricular groove, providing septal perforator branches to the anterior two-thirds of the interventricular septum and diagonal branches to the anterior left ventricular wall. The left circumflex artery travels in the atrioventricular groove, supplying obtuse marginal branches to the lateral left ventricular wall and, in some individuals, portions of the posterior left ventricle. Coronary dominance refers to which artery gives rise to the posterior descending artery. Right dominance occurs in 70% of the population, left dominance in 10%, and co-dominance where both arteries contribute in 20%. This anatomical variation has clinical significance during myocardial infarction, as the dominant artery supplies the inferior wall and AV node. Venous drainage of the heart occurs primarily through the coronary sinus, which empties into the right atrium. The great cardiac vein drains the anterior left ventricle, the middle cardiac vein drains the posterior left ventricle, and the small cardiac vein drains the right ventricle—all emptying into the coronary sinus. The anterior cardiac veins drain the right ventricle directly into the right atrium without passing through the coronary sinus. The Thebesian veins are small venous channels that drain directly from the myocardium into all cardiac chambers, contributing to the small physiological shunt in cardiac output. Panel A: Right coronary artery in red arising from right aortic sinus coursing in AV groove with SA nodal artery, acute marginal branches to right ventricle, and posterior descending artery on inferior surface. Panel B: Left main coronary artery from left aortic sinus bifurcating into LAD in anterior interventricular groove (with septal perforators and diagonal branches) and circumflex in left AV groove with obtuse marginals. Panel C: Posterior view showing coronary sinus with tributaries: great cardiac vein (blue), middle cardiac vein, and small cardiac vein draining into right atrium. Panel D: Territory labels indicating myocardial regions supplied by each artery. --- ## Unique Features of Coronary Blood Flow Coronary blood flow differs fundamentally from flow to other organs due to the unique mechanical environment created by the contracting myocardium. During systole, the contracting ventricular muscle compresses intramural coronary vessels, dramatically reducing blood flow. Consequently, 70-80% of left ventricular coronary flow occurs during diastole when the myocardium is relaxed and coronary vessels are uncompressed. Only 20-30% of left coronary flow occurs during systole. Right ventricular coronary flow is more uniform throughout the cardiac cycle because right ventricular intramural pressures are much lower than those in the left ventricle. The transmural distribution of coronary flow has important clinical implications. During systole, the subendocardium experiences the greatest compressive forces because intramyocardial pressure is highest near the ventricular cavity. Although diastolic flow compensates for systolic compression in the subendocardium, this layer remains the most vulnerable to ischemia. When coronary perfusion pressure falls or when diastole shortens (as in tachycardia), the subendocardium is the first region to become ischemic, explaining why subendocardial infarctions are common in conditions of compromised coronary flow. The myocardium has uniquely high oxygen extraction at rest—approximately 70-80% of delivered oxygen is extracted, compared to only 25% in most systemic tissues. The arteriovenous oxygen difference in coronary circulation is 12-14 mL/dL, compared to 4-5 mL/dL systemically. Because resting extraction is already near-maximal, the heart has minimal ability to increase oxygen extraction further. Therefore, when myocardial oxygen demand increases, the demand must be met almost entirely by increasing coronary blood flow rather than by extracting more oxygen from each unit of blood. Panel A: Graph plotting coronary blood flow against cardiac cycle with ECG trace showing left coronary artery flow (red) dipping during systole to 20-30% then rising sharply during diastole to 70-80%. Panel B: Right coronary artery flow (blue) showing more uniform pattern throughout cycle with diastolic flow area emphasized. Panel C: Ventricular wall cross-section with epicardium, midwall, and endocardium layers showing compressive forces during systole (highest at endocardium, lowest at epicardium). Panel D: Bar graph comparing oxygen extraction: coronary (70-80% tall red bar) versus systemic (25% short blue bar). --- ## Determinants of Myocardial Oxygen Demand Myocardial oxygen consumption (MVO₂) is determined primarily by three factors: wall tension (approximately 50% of demand), heart rate (approximately 30%), and contractility (approximately 20%). Understanding these determinants is essential for rational anti-ischemic therapy. Wall tension, or wall stress, is the major determinant of oxygen consumption and is described by the Law of LaPlace: wall stress equals pressure times radius divided by twice the wall thickness. Increases in left ventricular pressure (afterload) or left ventricular radius (preload and ventricular dilation) increase wall stress and therefore oxygen demand. Conversely, increased wall thickness, as occurs in hypertrophy, reduces wall stress. This explains why ventricular dilation in heart failure dramatically increases oxygen demand—the larger radius increases wall stress. Heart rate directly influences oxygen consumption because each heartbeat requires energy, and increasing the number of beats per minute proportionally increases oxygen demand. Additionally, tachycardia shortens diastole, reducing the time available for coronary perfusion while simultaneously increasing demand—a dangerous combination during ischemia. Contractility reflects the intrinsic vigor of myocardial contraction independent of loading conditions. Increased contractility (positive inotropy) requires greater ATP consumption and therefore greater oxygen delivery. Minor contributors to oxygen demand include external work (approximately 5%), basal cellular metabolism (approximately 5%), and electrical activation (minimal contribution). The tension-time index integrates left ventricular pressure over the duration of systole and correlates well with myocardial oxygen consumption. This index is increased by elevated systolic blood pressure, increased heart rate, and prolonged ejection time. Clinically, the rate-pressure product (heart rate multiplied by systolic blood pressure) serves as a practical estimate of myocardial oxygen demand. Panel A: Pie chart showing relative contributions to myocardial oxygen consumption: wall tension (50% largest red segment), heart rate (30% medium blue segment), contractility (20% smaller green segment). Panel B: Law of LaPlace illustration with left ventricle cross-section showing pressure (P) arrows outward, radius (r) from center to wall, wall thickness (h), and equation T = P x r / 2h. Panel C: Tension-time index graph with left ventricular pressure on y-axis and time on x-axis with shaded area under systolic curve. Panel D: Minor contributors to oxygen demand listed including external work and basal metabolism. --- ## Regulation of Coronary Blood Flow Coronary blood flow is regulated by multiple overlapping mechanisms, with metabolic factors serving as the primary regulators. When myocardial oxygen demand increases, metabolic byproducts accumulate and cause coronary vasodilation, precisely matching blood supply to metabolic needs. Adenosine is considered the primary metabolic mediator of coronary vasodilation. During increased metabolic activity or oxygen deficit, ATP is broken down to adenosine, which acts on A₂ receptors on vascular smooth muscle to increase cyclic AMP and cause relaxation. Other metabolic factors contributing to vasodilation include potassium ions (which hyperpolarize smooth muscle), carbon dioxide (which reduces local pH), hydrogen ions (which act directly on smooth muscle), and decreased oxygen tension (through multiple mechanisms). ATP-sensitive potassium channels open during metabolic stress, causing hyperpolarization and vasodilation, providing an additional link between cellular energy status and vascular tone. Endothelial cells produce several vasoactive substances that modulate coronary flow. Nitric oxide is continuously released from healthy endothelium and causes vasodilation, particularly in larger coronary arteries. Prostacyclin similarly promotes vasodilation and inhibits platelet aggregation. Endothelium-derived hyperpolarizing factor contributes to vasodilation in smaller vessels. Endothelin-1, a potent vasoconstrictor, is released in pathological conditions and contributes to coronary spasm and atherogenesis. Neural control of coronary vessels involves both sympathetic and parasympathetic influences, but metabolic factors typically override neural effects. Sympathetic stimulation activates alpha-adrenergic receptors causing vasoconstriction and beta₂-receptors causing vasodilation. During exercise, however, the increased metabolic demand produces such powerful vasodilatory signals that the net effect is coronary dilation despite sympathetic activation. Parasympathetic stimulation via muscarinic receptors produces mild coronary dilation, but its contribution to flow regulation is minor. The myogenic response contributes to coronary autoregulation: increased intravascular pressure causes smooth muscle contraction, while decreased pressure causes relaxation. This intrinsic response helps maintain constant flow despite pressure fluctuations. Panel A: Coronary arteriole with endothelium and smooth muscle layers showing metabolic pathways with adenosine, K+, CO2, H+, and hypoxia converging to promote vasodilation (green arrows). Panel B: Endothelial factors with endothelium releasing NO and PGI2 (green arrows for vasodilation) and endothelin-1 (red arrow for vasoconstriction). Panel C: Neural influences showing sympathetic fibers with dual effects (alpha-constriction in red, beta-2-dilation in green) and parasympathetic fibers with mild dilation. Panel D: Prominent "Metabolic Override" label showing metabolic signals dominate over neural input during increased demand. --- ## Coronary Autoregulation Coronary autoregulation is the intrinsic ability of the coronary circulation to maintain constant blood flow across a wide range of perfusion pressures, independent of neural control. This mechanism ensures that myocardial oxygen delivery remains adequate despite fluctuations in arterial pressure. The autoregulatory plateau extends from approximately 60 mmHg to 140 mmHg of coronary perfusion pressure. Within this range, coronary blood flow remains remarkably constant because changes in pressure are offset by changes in coronary vascular resistance. When pressure falls below 60 mmHg, coronary vessels are maximally dilated and flow decreases passively with pressure. When pressure exceeds 140 mmHg, the capacity for vasoconstriction is exceeded and flow rises passively. The mechanisms underlying autoregulation include both myogenic and metabolic responses. The myogenic response causes vascular smooth muscle to contract in response to increased pressure and relax in response to decreased pressure. However, metabolic regulation is the primary mechanism: when pressure falls and flow decreases, metabolic vasodilators accumulate and cause vasodilation to restore flow. Conversely, when pressure rises and flow increases, metabolic vasodilators are washed out, allowing vasoconstriction. Several pathological conditions impair coronary autoregulation. Coronary stenosis exhausts autoregulatory reserve because vessels downstream from a stenosis are already maximally dilated to compensate for the pressure drop across the lesion. Left ventricular hypertrophy may impair autoregulation due to altered vascular structure and increased extravascular compression. Diabetes mellitus impairs coronary autoregulation through endothelial dysfunction and altered vascular reactivity. Anemia shifts the autoregulatory curve because reduced oxygen-carrying capacity requires increased flow at any given pressure. Panel A: Coronary autoregulation graph with flow on y-axis and perfusion pressure on x-axis showing pressure-dependent zone below 60 mmHg where flow falls steeply. Panel B: Flat autoregulatory plateau between 60-140 mmHg (horizontal green band) with arrows showing vessels constricting when pressure increases and dilating when it decreases. Panel C: Pressure-dependent zone above 140 mmHg where flow rises again with inset diagrams showing vessel diameter at different pressures. Panel D: Dashed curve showing impaired autoregulation in coronary stenosis with narrower plateau and flow falling at higher pressures. --- ## Coronary Flow Reserve Coronary flow reserve represents the capacity of the coronary circulation to increase blood flow above resting levels in response to increased metabolic demand. It is defined as the ratio of maximum coronary blood flow to resting flow, with normal values ranging from 4 to 6—meaning coronary flow can increase four to six times above baseline when demand increases. Several methods exist for measuring coronary flow reserve. Intracoronary Doppler uses a guidewire-mounted sensor to measure flow velocity at rest and during hyperemia induced by adenosine. Positron emission tomography (PET) can measure absolute myocardial blood flow noninvasively. Fractional flow reserve (FFR) is a pressure-based measurement that assesses the physiological significance of a coronary stenosis by comparing the pressure distal to a lesion with the aortic pressure during maximum hyperemia—an FFR below 0.80 indicates hemodynamically significant disease. Maximum coronary flow depends on the capacity of the coronary resistance vessels to dilate fully. Epicardial coronary stenosis reduces maximum achievable flow by creating a fixed resistance in series with the microcirculation. Microvascular disease impairs maximum flow by limiting the capacity for arteriolar dilation. Left ventricular hypertrophy reduces maximum flow per gram of myocardium because capillary density does not increase proportionally with myocyte size. Anemia reduces functional oxygen delivery capacity even when flow is adequate. Coronary flow reserve values above 2.0 are generally considered normal. Values between 1.5 and 2.0 indicate mild impairment, while values below 1.5 represent significant impairment. When flow reserve is exhausted—meaning resting flow is already near-maximum—any further increase in demand cannot be met, and ischemia develops. This explains why patients with severe coronary stenosis may have adequate resting flow but develop ischemia during exertion. Panel A: Bar graphs showing resting coronary blood flow and maximum flow (4-6 times taller) with ratio labeled as coronary flow reserve (CFR). Panel B: Normal coronary artery scenario with wide flow reserve (tall bars) and moderately stenotic artery with reduced but adequate reserve. Panel C: Severely stenotic artery where resting flow is near maximum and any demand increase crosses ischemia threshold (red dashed line). Panel D: CFR color scale: green for greater than 2.0 (normal), yellow for 1.5-2.0 (mild impairment), red for less than 1.5 (significant impairment). --- ## Myocardial Ischemia Myocardial ischemia occurs when oxygen supply fails to meet oxygen demand, resulting in inadequate tissue perfusion for metabolic needs. This imbalance may result from decreased supply, increased demand, or reduced oxygen content of the blood. Decreased oxygen supply occurs with coronary artery stenosis, coronary vasospasm, or systemic hypotension reducing coronary perfusion pressure. Increased oxygen demand may precipitate ischemia when patients with borderline coronary reserve exercise, develop tachycardia, or experience hypertensive episodes. Reduced oxygen content due to severe anemia or hypoxemia can cause ischemia even with normal coronary arteries. The consequences of ischemia follow a predictable temporal sequence. Within seconds of reduced perfusion, electrical changes appear on the ECG as ST-segment alterations. Within less than one minute, diastolic dysfunction develops as calcium reuptake slows and the ventricle fails to relax properly. One to two minutes into ischemia, systolic dysfunction manifests as regional wall motion abnormalities visible on echocardiography. Anginal chest pain, contrary to popular assumption, is a relatively late manifestation occurring minutes after the onset of ischemia. Irreversible myocyte injury begins after 20-40 minutes of sustained ischemia. If ischemia continues for hours, transmural necrosis develops. This temporal sequence is termed the ischemic cascade: perfusion defect leads to metabolic abnormality, then diastolic dysfunction, systolic dysfunction, ECG changes, and finally angina. Importantly, angina is the last component of this cascade, meaning that silent ischemia—ischemia without chest pain—is common, and patients may have significant myocardial dysfunction before experiencing symptoms. Panel A: Horizontal timeline from 0-60 minutes showing at immediate onset (0 seconds) perfusion defect and metabolic changes with ATP depletion as declining curve, and at less than 1 minute diastolic dysfunction with stiff ventricle. Panel B: At 1-2 minutes systolic dysfunction with hypokinetic wall segment and at 2-5 minutes ECG changes (ST depression strip shown). Panel C: At 5+ minutes angina (figure holding chest) and at 20-40 minutes irreversible injury begins (crosshatched necrotic zone). Panel D: Balance diagram showing supply (coronary artery) and demand (heart with workload) tipped toward demand during ischemia. --- ## Coronary Artery Disease Atherosclerosis is the underlying pathology in most coronary artery disease. The disease progresses through identifiable stages beginning with fatty streaks composed of lipid-laden macrophages (foam cells) in the arterial intima. These evolve into fibrous plaques containing smooth muscle cells, collagen, and a lipid-rich core. Complicated plaques develop calcification, intraplaque hemorrhage, and may undergo rupture leading to thrombosis. The hemodynamic significance of coronary stenosis depends on the degree of luminal narrowing. Lesions less than 50% diameter stenosis rarely limit flow under any conditions. Stenoses of 50-70% may limit flow during hyperemia (exercise, stress) but not at rest. Stenoses greater than 70% typically limit both stress and resting flow. Stenoses greater than 90% severely compromise even resting flow and represent critical lesions. Plaque stability is as important as plaque size in determining clinical outcomes. Stable plaques have thick fibrous caps, small lipid cores, and low inflammatory activity, presenting low risk of rupture. Unstable (vulnerable) plaques have thin fibrous caps, large lipid cores, and intense inflammation, making them prone to rupture. Plaque rupture exposes thrombogenic material to flowing blood, triggering platelet aggregation and thrombus formation—the proximate cause of most acute coronary syndromes. Collateral circulation provides an alternative blood supply when main coronary vessels become occluded. Collateral vessels develop gradually in response to chronic ischemia, driven by angiogenic factors such as vascular endothelial growth factor (VEGF). Well-developed collaterals can provide significant protection against infarction when the native vessel occludes. Exercise training promotes collateral development. Patients with chronic stable angina often have better collateral networks than those with sudden occlusion. Panel A: Atherosclerosis evolution from normal artery to fatty streak to fibrous plaque to complicated plaque with rupture showing wall layers (intima, media, adventitia) with progressive changes. Panel B: Stable plaque with thick fibrous cap (dense blue), small lipid core (yellow), minimal inflammatory cells compared to unstable plaque with thin cap, large lipid core, abundant inflammation, and rupture with thrombus. Panel C: Collateral vessel development with dotted lines representing new vessels connecting occluded artery territory to adjacent patent arteries. Panel D: Hemodynamic significance of stenosis degrees: less than 50% (rarely limiting), 50-70% (limits hyperemic flow), greater than 70% (limits resting flow). --- ## Clinical Presentations Stable angina pectoris results from a fixed coronary stenosis that limits flow during increased demand. Patients typically describe substernal pressure or squeezing that radiates to the left arm, jaw, or back. Episodes are triggered by exertion, emotional stress, or other factors that increase myocardial oxygen demand. The discomfort lasts 2-10 minutes and is relieved by rest or sublingual nitroglycerin. The underlying pathophysiology is demand ischemia—the stenosis limits the ability to increase flow when demand rises. Unstable angina represents a more dangerous condition with plaque rupture and non-occlusive thrombus formation. Patterns that suggest unstable angina include new-onset angina, angina at rest, or a significant acceleration in frequency or severity of previously stable angina. Without treatment, unstable angina frequently progresses to myocardial infarction. Management includes hospitalization, antiplatelet and anticoagulant therapy, and often urgent revascularization. Myocardial infarction occurs when coronary occlusion causes sustained ischemia leading to myocyte death. ST-elevation myocardial infarction (STEMI) results from complete coronary occlusion and produces transmural injury visible as ST elevation on ECG. Non-ST-elevation myocardial infarction (NSTEMI) results from partial occlusion or complete occlusion with collateral flow, producing subendocardial injury with ST depression or T-wave changes. Variant (Prinzmetal) angina results from coronary artery spasm rather than fixed obstruction. Patients experience angina at rest, often at night or in the early morning. ECG during episodes shows ST elevation rather than depression. Coronary angiography may show normal or minimally diseased arteries. Treatment centers on calcium channel blockers and nitrates; beta-blockers may worsen spasm by allowing unopposed alpha-mediated vasoconstriction. Panel A: Stable angina showing figure exercising with chest discomfort resolving with rest alongside coronary artery with fixed stenosis reducing but not eliminating blood flow. Panel B: Unstable angina showing ruptured plaque with non-occlusive thrombus and symptoms at rest. Panel C: STEMI showing complete occlusion with transmural injury (full-thickness red zone) and ST elevation; NSTEMI showing partial occlusion with subendocardial injury and ST depression. Panel D: Variant angina showing spasm of angiographically normal coronary artery with ST elevation during episode occurring at rest, often nocturnal. --- ## Therapeutic Principles Anti-ischemic therapy aims to restore the balance between oxygen supply and demand. Nitrates reduce preload through venodilation, decreasing ventricular volume and wall tension, thereby reducing oxygen demand. Nitrates also dilate coronary arteries, increasing oxygen supply, particularly in variant angina. Beta-blockers reduce heart rate and contractility, lowering oxygen demand substantially. Calcium channel blockers reduce heart rate (non-dihydropyridine agents), decrease contractility, and dilate coronary arteries, addressing both sides of the supply-demand equation. Ranolazine works through a novel mechanism, inhibiting the late sodium current to reduce calcium overload and improve diastolic function. Revascularization directly restores blood supply to ischemic myocardium. Percutaneous coronary intervention (PCI) with stenting is preferred for focal lesions and in acute coronary syndromes requiring urgent revascularization. Coronary artery bypass grafting (CABG) provides better long-term outcomes for patients with multivessel disease, left main coronary stenosis, or diabetes mellitus. The choice between PCI and CABG depends on coronary anatomy, patient comorbidities, and heart team assessment. Secondary prevention reduces the risk of future cardiovascular events. Antiplatelet therapy with aspirin and P2Y₁₂ inhibitors (clopidogrel, prasugrel, ticagrelor) prevents thrombosis, particularly after stent placement. Statins provide lipid lowering and plaque stabilization independent of lipid effects. ACE inhibitors provide vascular protection, reduce remodeling, and improve outcomes in patients with reduced ejection fraction. Lifestyle modification including smoking cessation, exercise, diet optimization, and weight management forms the foundation of secondary prevention. Acute myocardial infarction requires emergency reperfusion. Primary PCI is preferred when available within 90-120 minutes of first medical contact. Fibrinolytic therapy is an alternative when PCI is not available in a timely manner. Adjunctive therapy includes antiplatelet agents, anticoagulation, and supportive care. Long-term management focuses on limiting infarct size, preventing remodeling, and reducing the risk of recurrent events. Panel A: Supply-demand balance scale showing nitrates and beta-blockers reducing demand (heart with decreased workload) and nitrates and calcium channel blockers increasing supply (widened coronary artery). Panel B: Revascularization showing angiogram of focal stenosis suitable for PCI with stent deployment illustrated. Panel C: Multivessel disease suitable for CABG with bypass grafts illustrated. Panel D: Secondary prevention pyramid with lifestyle at base, then antiplatelet therapy, statins, ACE inhibitors, and blood pressure/diabetes control at higher levels. --- ## Summary Coronary blood flow is unique in that 70-80% occurs during diastole due to systolic compression of intramural vessels. The subendocardium experiences the greatest compressive forces and is therefore most vulnerable to ischemia. The heart extracts 70-80% of delivered oxygen at rest, meaning increased oxygen demand must be met by increased flow rather than increased extraction. Myocardial oxygen demand is determined primarily by wall tension, heart rate, and contractility. Metabolic regulation, with adenosine as the primary mediator, predominates over neural control in matching coronary flow to myocardial needs. Coronary autoregulation maintains constant flow across perfusion pressures from 60 to 140 mmHg. Coronary flow reserve—the ratio of maximum to resting flow—normally ranges from 4 to 6 times baseline. When reserve is exhausted, any increase in demand produces ischemia. The ischemic cascade progresses from perfusion defect through metabolic changes, diastolic dysfunction, systolic dysfunction, and ECG changes before angina develops. Stable angina results from fixed stenosis causing demand ischemia, while acute coronary syndromes result from plaque rupture and thrombosis causing supply ischemia. Anti-ischemic therapy addresses the supply-demand balance through nitrates, beta-blockers, and calcium channel blockers. Revascularization with PCI or CABG restores supply. Secondary prevention reduces recurrent events. --- ## Key Terms | Term | Definition | |------|------------| | Coronary flow reserve | Ratio of maximum to resting coronary blood flow, normally 4-6x baseline | | Autoregulation | Intrinsic ability to maintain constant flow across a range of perfusion pressures (60-140 mmHg) | | Tension-time index | Integration of left ventricular pressure over systole; correlates with myocardial oxygen consumption | | Ischemic cascade | Temporal sequence from perfusion defect to angina: metabolic changes, diastolic then systolic dysfunction, ECG changes, symptoms | | Fractional flow reserve | Pressure ratio (Pd/Pa during hyperemia) used to assess the hemodynamic significance of coronary stenosis | | Collateral circulation | Alternative blood supply pathways that develop in response to chronic coronary occlusion | --- *This content is subject to the [MIT License](https://opensource.org/licenses/MIT). © 2024–2026 Hibbert School of Medicine.*